+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of clinical pharmacy specialists on glycemic control in veterans with type 2 diabetes



Impact of clinical pharmacy specialists on glycemic control in veterans with type 2 diabetes



American Journal of Health-System Pharmacy 76(Suppl._1): S9-S14



The results of a study to determine the impact that Patient Aligned Care Team clinical pharmacy specialists (CPSs) have in improving glycemic control among veterans with type 2 diabetes are reported. Reductions in glycosylated hemoglobin (HbA1c) values in diabetic patients are associated with improved outcomes related to vascular complications. Current diabetes management strategies at the Cincinnati Veteran Affairs Medical Center (VAMC) involve a multidisciplinary approach that includes visits with a CPS by veterans referred by a primary care provider. A retrospective chart review-based study of veterans who received CPS care for diabetes management was conducted. The primary outcome was HbA1c reduction after up to 18 months of CPS care; subgroup analyses by type of clinic visit (face-to-face versus telephone), age group, Care Assessment Need (CAN) Score, and number of visits within an 18-month time frame were performed. There was a 2.2% absolute reduction in the mean HbA1c value among veterans receiving CPS care for up to 18 months. There was no statistically significant difference in absolute HbA1c reduction by type of clinic visit. The greatest absolute HbA1c reduction was observed in the following subgroups: 60- to 69-year-old veterans, veterans with a CAN score of ≥90, and veterans who had 5 or more CPS visits. CPSs at the Cincinnati VAMC significantly reduced the HbA1c of uncontrolled, complex diabetic veterans. The reduction in HbA1c was greatest in patients who had more than 5 encounters with a CPS over the 18-month data collection period.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066486717

Download citation: RISBibTeXText

PMID: 30753315

DOI: 10.1093/ajhp/zxy015


Related references

Evaluating glycemic control for patient-aligned care team clinical pharmacy specialists at a large Veterans Affairs medical center. Pharmacy Practice 16(2): 1164, 2018

Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care 23(10): 1478-1485, 2000

Comparison of clinical pharmacy specialists and primary care physicians in treatment of type 2 diabetes mellitus in rural Veterans Affairs facilities. American Journal of Health-System Pharmacy 75(5 Suppl. 1): S6-S12, 2018

Differential Impact of Homelessness on Glycemic Control in Veterans with Type 2 Diabetes Mellitus. Journal of General Internal Medicine 31(11): 1331-1337, 2016

Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 26(6): 1759-1763, 2003

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Archives of Internal Medicine 157(2): 181-188, 1997

Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data. Journal of Managed Care and Specialty Pharmacy 20(7): 691-700, 2015

Impact of Clinical Pharmacy Specialists on the Design and Implementation of a Quality Improvement Initiative to Decrease Inappropriate Medications in a Veterans Affairs Emergency Department. Journal of Managed Care and Specialty Pharmacy 22(1): 74-80, 2016

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2 Veterans Affairs Diabetes Trial. Journal of Diabetes & its Complications 17(6): 314-322, November-December, 2003

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 18(8): 1113-1123, 1995

Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. General Hospital Psychiatry 30(6): 509-514, 2008

Evaluating the effect of u-500 insulin therapy on glycemic control in veterans with type 2 diabetes. Clinical Diabetes 33(1): 14-19, 2015

Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes. Medical Care 48(6): 527-533, 2010

Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus. Journal of Diabetes and Its Complications 25(3): 143-150, 2011

Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study. Diabetes Therapy 6(3): 339-355, 2015